On March 12, 2026, Plus Therapeutics, Inc. (Nasdaq: PSTV) shared its financial results for the fourth quarter and full year ending on December 31, 2025. Plus, a healthcare firm specializing in precision diagnostics and radiopharmaceuticals for CNS cancers, outlined recent and forthcoming business highlights.
